NIH-funded research R01 grant

How body composition affects survival in breast cancer patients

Official title: Body composition and breast cancer survival: immune and metabolic biomarkers in breast tumors

Funded at Kaiser Foundation Research Institute · NIH-10873125 · Data updated 2026-11-12

This study is looking at how having low muscle and extra fat might affect breast cancer survival and treatment outcomes, and it aims to help create better, personalized therapies for breast cancer patients.

More Breast Cancer research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionKaiser Foundation Research Institute
NIH-funded
Lab location1 site (Oakland, UNITED STATES)
Project startJuly 1, 2020
Project endJune 30, 2026
Funding year2024
Award (this year)$100,924
NIH project number5R01CA251589-05
Project IDNIH-10873125 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are breast cancer patients who have low muscle mass or excess adiposity.

Less likely to help

Patients with normal body composition and no metabolic syndrome may not benefit from this research.

What this research studies

This research investigates the relationship between body composition, specifically low muscle mass and excess fat, and breast cancer survival. It aims to understand how these factors influence the immune response and metabolic pathways in breast tumors. By studying human breast cancer patients, the research seeks to uncover how adverse body composition may lead to worse treatment outcomes and increased risk of recurrence. The study will analyze immune responses and signaling pathways to develop personalized therapies for breast cancer patients.

Why it matters

Potential benefit: If successful, this research could lead to improved treatment strategies and better survival rates for breast cancer patients with adverse body composition.

How similar studies have gone: Other research has shown promising results in understanding the impact of body composition on cancer outcomes, suggesting this approach could yield valuable insights.

Where this research is happening

  • Kaiser Foundation Research Institute
    Oakland, United States
    Active

Researchers

  • Principal investigator: Feliciano, Elizabeth Marjorie Cespedes — Kaiser Foundation Research Institute
  • Study coordinator: Feliciano, Elizabeth Marjorie Cespedes

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.